Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | NQO1 | P15559 | 1/20 | 0.56 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111274 | 1.00 | AGXT (0.63) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL30209608 | 1.00 | AGXT (0.63) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL17629449 | 1.00 | AGXT (0.63) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL27786463 | 0.98 | AGXT (0.61) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL27786466 | 0.98 | AGXT (0.61) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL27786460 | 0.98 | AGXT (0.61) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| Methyl Alcohol SCHEMBL27786467 | 0.96 | AGXT (0.59) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| Formaldehyde SCHEMBL28727752 | 0.94 | MAPK1 (0.61) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| Ether SCHEMBL17634330 | 0.94 | MAPK1 (0.60) | AGXTMAPK1TDP1GAAL3MBTL1 | |
| SCHEMBL19910986 | 0.92 | CYP11B1 (0.64) | AGXTMAPK1TDP1GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-14 | — | — | US | claimed |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | PROCTER & GAMBLE (US) | 2026-01-01 | — | — | US | claimed |
| US-12509643-B2 | Pro-benefit-agent compounds with carbon/nitrogen bonds | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-30 | — | — | US | claimed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| EP-4581114-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Novozymes A/S (DK) | 2025-07-09 | — | — | EP | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| US-20250163343-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | INTERNATIONAL FLAVORES & FRAGRANCES INC. | 2025-05-22 | — | — | US | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| CN-119698458-A | Improvements in or relating to organic compounds improvements relating to organic compounds | 诺维信公司 | 2025-03-25 | — | — | CN | claimed |
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| US-20230002330-A1 | PRO-BENEFIT-AGENT COMPOUNDS WITH HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY | 2023-01-05 | — | — | US | claimed |
| US-20220403297-A1 | PRO-BENEFIT-AGENT COMPOUNDS WITH CARBON/NITROGEN BONDS | THE PROCTER & GAMBLE COMPANY | 2022-12-22 | — | — | US | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| WO-2022251818-A1 | PRO-BENEFIT-AGENT COMPOUNDS WITH HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022251817-A1 | PRO-BENEFIT AGENT COMPOUNDS WITH CARBON/NITROGEN BONDS | THE PROCTER & GAMBLE COMPANY (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| WO-2022129351-A1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH SA (CH) | 2022-06-23 | — | — | WO | claimed |
| WO-2022126093-A1 | TREATMENT COMPOSITIONS WITH PRO-FRAGRANCE SILICONE POLYMERS THAT COMPRISE HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-16 | — | — | WO | claimed |
| US-20220177813-A1 | TREATMENT COMPOSITIONS WITH PRO-FRAGRANCE SILICONE POLYMERS THAT COMPRISE HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY | 2022-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509643-B2 | Pro-benefit-agent compounds with carbon/nitrogen bonds | HGFAC, PROKR1, FABP2 | AGXT 675/4885MAPK1 2688/4885TDP1 4534/4885 |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | ARGLU1, DAO, PNISR | AGXT 250/4885MAPK1 958/4885TDP1 1734/4885 |
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | F2, C9, S100A8 | AGXT 558/4885MAPK1 4549/4885TDP1 3522/4885 |
| US-20230002330-A1 | PRO-BENEFIT-AGENT COMPOUNDS WITH HETEROCYCLIC MOIETIES | PLG, PAM, PREP | AGXT 109/4885MAPK1 3032/4885TDP1 1923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.